The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Dysferlin is a Plasma Membrane Protein and is Expressed Early in Human Development
Abstract
Recently, a single gene, DYSF, has been identified which is mutated in patients with limb-girdle muscular dystrophy type 2B (LGMD2B) and with Miyoshi myopathy (MM). This is of interest because these diseases have been considered as two distinct clinical conditions since different muscle groups are the initial targets. Dysferlin, the protein product of the gene, is a novel molecule without homology to any known mammalian protein. We have now raised a monoclonal antibody to dysferlin and report on the expression of this new protein: immunolabelling with the antibody (designated NCL-hamlet) demonstrated a polypeptide of approximately 230 kDa on western blots of skeletal muscle, with localization to the muscle fibre membrane by microscopy at both the light and electron microscopic level. A specific loss of dysferlin labelling was observed in patients with mutations in the LGMD2B/MM gene. Furthermore, patients with two different frameshifting mutations demonstrated very low levels of immunoreactive protein in a manner reminiscent of the dystrophin expressed in many Duchenne patients. Analysis of human fetal tissue showed that dysferlin was expressed at the earliest stages of development examined, at Carnegie stage 15 or 16 (embryonic age 5-6 weeks). Dysferlin is present, therefore, at a time when the limbs start to show regional differentiation. Lack of dysferlin at this critical time may contribute to the pattern of muscle involvement that develops later, with the onset of a muscular dystrophy primarily affecting proximal or distal muscles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The American Journal of Human Genetics
S., J. (1950) · Population (French Edition) · doi:10.2307/1523704 · Cited by 5,028
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
Kearney, J. F., Radbruch, A., Liesegang, B., & Rajewsky, K. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.4.1548 · Cited by 1,852
McDonald, C. M., Abresch, R. T., Carter, G. T., Fowler, W. M., Johnson, E. R., Kilmer, D. D., & Sigford, B. J. (1995) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/00002060-199509001-00003 · Cited by 1,069
Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A
Richard, I., Broux, O., Allamand, V., Fougerousse, F., Chiannilkulchai, N., Bourg, N., Brenguier, L., Devaud, C., Pasturaud, P., Roudaut, C., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90368-2 · Cited by 1,001
Self-citationLiu, J., Aoki, M., Illa, I., Wu, C., Fardeau, M., Angelini, C., Serrano, C., Urtizberea, J. A., Hentati, F., Hamida, M. B., et al. (1998) · Nature Genetics · doi:10.1038/1682 · Cited by 924
Bashir, R., Britton, S., Strachan, T., Keers, S., Vafiadaki, E., Lako, M., Richard, I., Marchand, S., Bourg, N., Argov, Z., et al. (1998) · Nature Genetics · doi:10.1038/1689 · Cited by 688
Self-citationMutations in the laminin α2–chain gene (LAMA2) cause merosin–deficient congenital muscular dystrophy
Helbling-Leclerc, A., Zhang, X., Topaloglu, H., Cruaud, C., Tesson, F., Weissenbach, J., Tomé, F. M. S., Schwartz, K., Fardeau, M., Tryggvason, K., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-216 · Cited by 632
Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
Minetti, C., Sotgia, F., Bruno, C., Scartezzini, P., Broda, P., Bado, M., Masetti, E., Mazzocco, M., Egeo, A., Donati, M. A., et al. (1998) · Nature Genetics · doi:10.1038/ng0498-365 · Cited by 598
Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular Dystrophy
Noguchi, S., McNally, E. M., Othmane, K. B., Hagiwara, Y., Mizuno, Y., Yoshida, M., Yamamoto, H., Bönnemann, C. G., Gussoni, E., Denton, P. H., et al. (1995) · Science · doi:10.1126/science.270.5237.819 · Cited by 506
Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy
Roberds, S. L., Leturcq, F., Allamand, V., Piccolo, F., Jeanpierre, M., Anderson, R. D., Lim, L. E., Lee, J. C., Tomé, F. M. S., Romero, N. B., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90527-4 · Cited by 454
Self-citationβ–sarcoglycan: characterization and role in limb–girdle muscular dystrophy linked to 4q12
Lim, L. E., Duclos, F., Broux, O., Bourg, N., Sunada, Y., Allamand, V., Meyer, J., Richard, I., Moomaw, C., Slaughter, C., et al. (1995) · Nature Genetics · doi:10.1038/ng1195-257 · Cited by 447
Self-citationBönnemann, C. G., Modi, R., Noguchi, S., Mizuno, Y., Yoshida, M., Gussoni, E., McNally, E. M., Duggan, D. J., Angelini, C., Hoffman, E. P., et al. (1995) · Nature Genetics · doi:10.1038/ng1195-266 · Cited by 445
Nigro, V., Moreira, E. D. S., Piluso, G., Vainzof, M., Belsito, A., Politano, L., Puca, A. A., Passos-Bueno, M. R., & Zatz, M. (1996) · Nature Genetics · doi:10.1038/ng1096-195 · Cited by 423
The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced
Tennyson, C. N., Klamut, H. J., & Worton, R. G. (1995) · Nature Genetics · doi:10.1038/ng0295-184 · Cited by 369
Mutations in the integrin α7 gene cause congenital myopathy
Hayashi, Y. K., Chou, F.-L., Engvall, E., Ogawa, M., Matsuda, C., Hirabayashi, S., Yokochi, K., Ziober, B. L., Kramer, R. H., Kaufman, S. J., et al. (1998) · Nature Genetics · doi:10.1038/ng0598-94 · Cited by 366
Weiler, T., Bashir, R., Anderson, L. V. B., Davison, K., Moss, J. A., Britton, S., Nylen, E., Keers, S., Vafiadaki, E., Greenberg, C. R., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.871 · Cited by 184
Self-citationDystrophin in skeletal muscle I. Western blot analysis using a monoclonal antibody
Nicholson, L. V. B., Davison, K., Falkous, G., Harwood, C., O'Donnell, E., Slater, C. R., & Harris, J. B. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90223-2 · Cited by 165
Self-citationShiga, N., Takeshima, Y., Sakamoto, H., Inoue, K., Yokota, Y., Yokoyama, M., & Matsuo, M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119757 · Cited by 152
Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy
Nicholson, L. V. B., Johnson, M. A., Gardner‐Medwin, D., Bhattacharya, S. S., & Harris, J. B. (1990) · Acta Neuropathologica · doi:10.1007/bf00294640 · Cited by 152
Self-citationDystrophin in skeletal muscle II. Immunoreactivity in patients with Xp21 muscular dystrophy
Nicholson, L. V. B., Davison, K., Johnson, M. A., Slater, C. R., Young, C., Bhattacharya, S. S., Gardner‐Medwin, D., & Harris, J. B. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90224-4 · Cited by 142
Self-citationThe Seventh Form of Autosomal Recessive Limb-Girdle Muscular Dystrophy Is Mapped to 17q11-12
Moreira, E. S., Vainzof, M., Marie, S. K., Sertie, A. L., Zatz, M., & Passos‐Bueno, M. R. (1997) · The American Journal of Human Genetics · doi:10.1086/513889 · Cited by 132
Ultrastructural localization of dystropin in human muscle by using gold immunolabelling
Cullen, M. J., Walsh, J., Nicholson, L. V. B., & Harris, J. B. (1990) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1990.0034 · Cited by 116
Self-citationWeiler, T., Greenberg, C. R., Zelinski, T., Nylen, E., Coghlan, G., Crumley, M. J., Fujiwara, T. M., Morgan, K., & Wrogemann, K. (1998) · The American Journal of Human Genetics · doi:10.1086/301925 · Cited by 115
Nicholson, L. V. B., Johnson, M. A., Bushby, K. M. D., Gardner‐Medwin, D., Curtis, A., Ginjaar, I. B., den Dunnen, J. T., Welch, J. L., Butler, T. J., & Bakker, E. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.9.728 · Cited by 95
Self-citationThanh, L. T., Nguyen, T. M., Helliwell, T. R., et al. (1995) · PubMed · Cited by 92
Weiler, T., Greenberg, C. R., Nylen, E. G., Halliday, W., Morgan, K., Eggertson, D., & Wrogemann, K. (1996) · PubMed Central · Cited by 88
Prevalence of dystrophin-positive fibers in 85 duchenne muscular dystrophy patients
Fanin, M., Danieli, G. A., Vitiello, L., et al. (1992) · Neuromuscular Disorders · doi:10.1016/0960-8966(92)90025-2 · Cited by 57
Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?
Wilton, S. D., Dye, D. E., Blechynden, L. M., & Laing, N. G. (1997) · Neuromuscular Disorders · doi:10.1016/s0960-8966(97)00058-8 · Cited by 53
The “rescue” of dystrophin synthesis in boys with Duchenne muscular dystrophy
Nicholson, L. V. B. (1993) · Neuromuscular Disorders · doi:10.1016/0960-8966(93)90109-w · Cited by 31
Ultrastructural localization of adhalin, α‐dystroglycan and merosin in normal and dystrophic muscle
Cullen, M. J., Walsh, J., Roberds, S. L., et al. (1996) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1996.tb00843.x · Cited by 25
Self-citation
Cited by
Defective membrane repair in dysferlin-deficient muscular dystrophy
Bansal, D., Miyake, K., Vogel, S. S., Groh, S., Chen, C.-C., Williamson, R., McNeil, P. L., & Campbell, K. P. (2003) · Nature · doi:10.1038/nature01573 · Cited by 1,022
Muchir, A. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1453 · Cited by 616
Molecular basis of muscular dystrophies
Cohn, R. D., & Campbell, K. P. (2000) · Muscle & Nerve · doi:10.1002/1097-4598(200010)23:10<1456::aid-mus2>3.0.co;2-t · Cited by 538
Membrane Repair: Mechanisms and Pathophysiology
Cooper, S. T., & McNeil, P. L. (2015) · Physiological Reviews · doi:10.1152/physrev.00037.2014 · Cited by 386
Fujita, E., Kouroku, Y., Isoai, A., Kumagai, H., Misutani, A., Matsuda, C., Hayashi, Y. K., & Momoi, T. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm002 · Cited by 342
Metadata
- Authors
- Anderson, L. V. B., Davison, K., Moss, J. A., Young, C., Cullen, M. J., Walsh, J., Johnson, M. A., Bashir, R., Britton, S., Keers, S., Argov, Z., Mahjneh, I., Fougerousse, F., Beckmann, J. S., & Bushby, K. M. D.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-05-01
- Volume
- 8
- Issue
- 5
- Pages
- 855-861
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2102958109
- Cited by
- 302
- References
- 31
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.